Neiepirkto parenterāli ievadāmo zāļu iegāde onkoloģisko saslimšanu ārstēšanai 2019.gadam
Nacionālais veselības dienests
Published and bidding deadline .
Integrity Indicators
1 out of 3- No disputes from bidders or outsiders
- Sellers have recently made political party donations
- Bidding period is associated with an increased risk factor
Estimated Cost
Actual Cost
Duration
34 daysBidders
0 biddersBids
0 bidsDisputes
0 disputesNeiepirkto parenterāli ievadāmo zāļu iegāde onkoloģisko saslimšanu ārstēšanai 2019.gadam
| Process Type | Open procedure |
|---|---|
| Offers Revealed At |
Contracts
| Non-disclosed | |||||||||||||||
Non-disclosedaward-10. Bleomycinum 30000 IU Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-11. Epirubicinum 2 mg/ ml - 10 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-12. Epirubicinum 2 mg/ ml - 5 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-13. Doxorubicinum 2 mg/ ml - 5 ml; 10 mg Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-14. Etoposidum 20 mg/ ml - 20 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-15. Vinorelbinum 10 mg/ ml - 1 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-16. Vincristinum 1 mg/ ml - 5 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-17. Vincristinum 1 mg/ ml - 2 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-18. Cytarabinum 10 mg/ ml - 5 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-19. Cytarabinum 100 mg/ ml - 50 ml Signed . | Non-disclosed | |||||||||||||||
| Non-disclosed | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
Non-disclosedaward-20. Cytarabinum 100 mg/ ml - 5 ml Signed . | Non-disclosed | |||||||||||||||
| Non-disclosed | |||||||||||||||
| Non-disclosed | |||||||||||||||
Political donations by board-members prior to contract totalling €15,000.
| ||||||||||||||||
| Non-disclosed | |||||||||||||||
Non-disclosedaward-24. Fludarabinum 25 mg/ ml - 2 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-25. Methotrexatum 100 mg/ ml - 50 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-26. Methotrexatum 100 mg/ ml - 10 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-27. Methotrexatum 100 mg/ ml - 5 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-28. Granisetronum 1 mg/ ml - 1 ml Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-29. Calcii folinatum 10 mg/ ml - 20 ml Signed . | Non-disclosed | |||||||||||||||
| Non-disclosed | |||||||||||||||
Non-disclosedaward-4. (L-) Asparaginasum 10000 IU Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-5. (L-) Asparaginasum 5000 IU Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-6. Mitomycinum 40 mg Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-7. Mitomycinum 20 mg Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-8. Mitomycinum 10 mg Signed . | Non-disclosed | |||||||||||||||
Non-disclosedaward-9. Mitomycinum 2 mg Signed . | Non-disclosed | |||||||||||||||